Skip to main content

Characterization of messenger RNA from the cerebral cortex of control and Alzheimer-afflicted brain.

Guillemette JG, Wong L, Crapper McLachlan DR, Lewis PN

Publication: J Neurochem (1986) • Vol 47 • Page 987-97PMID: 2426413View on PubMed

Purpose

The purpose of this paper was to determine the effects of Alzheimer's disease on RNA yield, integrity, degradation rate, and in vitro translation capability and on the expression of the fever induced heat shock protein 70 (HSP70).

Conclusion

Polyadenylated (poly(A)), but not total or unpolyadenylated RNA yield was significantly lower as a percentage of total RNA in the patients with Alzheimer's disease when compared with the control group. Alkaline ribonuclease (RNase) activity, poly(A) size distributions, and poly(A) tail length were similar in Alzheimer's and control groups indicating differential degradation or column affinity are unlikely to be responsible. In vitro translation using poly(A) mRNA from Alzheimer's disease patients yielded 1.76 times more protein per ug poly(A) RNA than controls or Huntington's disease patients, but gel electrophoresis showed less protein not more. Consequently the authors hypothesize the increased RNA translation most likely represents an increase in insoluble protein. Fever at the time of death was associated with an increase in the expression of the stress related protein HSP-70. Although HSP-70 expression was increased by fever in all patients, the levels observed after fever in Alzheimer's disease patients when compared to normal or Huntington's disease patients with a similar fever profile were lower. The authors conclude that Alzheimer's disease is associated with a specific loss of poly(A) RNA, higher in vitro translation capability but less visualized protein and decreased fever induction of HSP-70.

Studies (3)

Purpose

The purpose of this study was to determine if Alzheimer's disease alters RNA adenylation rates, RNase activity, transcript size distribution, or tail length.

Summary of Findings

Although two different methods of RNA isolation provided differing total RNA yields, in both cases no significant difference in total RNA was observed between patients with Alzheimer's disease and those with no neurological diagnosis using either method. RNA yield was also independent of patient age (50-87 y) and postmortem interval (3-24 h). Poly(A) RNA yield was significantly lower as a percentage of total RNA in the patients with Alzheimer's disease (0.76%) when compared with the control group (1.3%), but no corresponding change in the unpolyadenylated fraction was observed. RNase activity tended to be higher in the Alzheimer's disease patients (20 +/-15 units/mg) than in control (12 +/-16 units/mg) but the difference was not significant (p>0.15) and thus is not likely to account for the decrease in poly(A) RNA. Densitometric analysis of northern blots showed that the distribution of poly(A) RNA did not appear to be different in Alzheimer's disease patients than in controls indicating differential degradation is also unlikely. Additionally, the length of the poly(A) tails was also unchanged between Alzheimer's disease and control groups so differences observed in total poly(A) are not due to differential column binding affinity. The authors conclude that in Alzheimer's disease there is a specific loss of poly(A) RNA that is not attributable to differences in RNAse activity, degradation or tail length.
  • Biospecimens

    TissueBrain
  • Preservation Types

    Frozen
  • Diagnoses

    Alzheimer's Disease
    Autopsy
    Normal
  • Platforms

    RNASpectrophotometry
    RNANorthern blot
    ProteinEnzyme assay
    RNARadioassay
    RNAColorimetric assay
  • Pre-analytical Factors

    ClassificationPre-Analytical FactorValue(s)
    PreaquisitionDiagnosis/ patient condition
    Alzheimer's disease
    Control